Status:
COMPLETED
Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male Subjects
Lead Sponsor:
UCB Pharma
Conditions:
Healthy Volunteers
Eligibility:
MALE
20-60 years
Phase:
PHASE1
Brief Summary
To evaluate the safety and tolerability of CDP6038 following single dose subcutaneous (sc) administration of CDP6038 to Japanese subjects. To evaluate the Pharmacokinetics of CDP6038 following single...
Eligibility Criteria
Inclusion
- Healthy Japanese volunteers
Exclusion
- Subject has participated in any other clinical drug study (including a biologic product or a medical device) within 5 PK half-lives or 3 months (whichever is longer) prior to Screening, or the subject is currently participating in another clinical study.
- Subject is not healthy (eg, taking any drug treatments, any psychological or emotional problems, a drug/alcohol abuse or a having a history of drug/alcohol abuse, having abnormal safety parameters)
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01262794
Start Date
November 1 2010
End Date
September 1 2011
Last Update
September 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guildford, Surrey, United Kingdom